Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy.
Allen KJH, Frank C, Jiao R, Malo ME, Bello M, De Nardo L, Meléndez-Alafort L, Dadachova E. Allen KJH, et al. Among authors: melendez alafort l. ACS Omega. 2024 Dec 4;9(50):50000-50011. doi: 10.1021/acsomega.4c09450. eCollection 2024 Dec 17. ACS Omega. 2024. PMID: 39713652 Free PMC article.
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.
González-Rueda S, García-Pérez O, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Ramírez-Nava G, Vargas-Ahumada J, Azorín-Vega E, Ferro-Flores G, Meléndez-Alafort L. González-Rueda S, et al. Among authors: melendez alafort l. Pharmaceutics. 2024 Oct 24;16(11):1358. doi: 10.3390/pharmaceutics16111358. Pharmaceutics. 2024. PMID: 39598482 Free PMC article.
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases.
De Nardo L, Santi S, Dalla Pietà A, Ferro-Flores G, Azorín-Vega E, Nascimbene E, Barbieri V, Zorz A, Rosato A, Meléndez-Alafort L. De Nardo L, et al. Among authors: melendez alafort l. EJNMMI Phys. 2024 Nov 13;11(1):94. doi: 10.1186/s40658-024-00696-2. EJNMMI Phys. 2024. PMID: 39535653 Free PMC article.
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V.
Mou L, De Dominicis L, Cisternino S, Skliarova H, Campostrini M, Rigato V, De Nardo L, Meléndez-Alafort L, Esposito J, Haddad F, Pupillo G. Mou L, et al. Among authors: melendez alafort l. Pharmaceuticals (Basel). 2023 Dec 23;17(1):26. doi: 10.3390/ph17010026. Pharmaceuticals (Basel). 2023. PMID: 38256860 Free PMC article.
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery.
Jalilian AR, Ocampo-García B, Pasanphan W, Sakr TM, Melendez-Alafort L, Grasselli M, Lugao AB, Yousefnia H, Dispenza C, Janib SM, Khan IU, Maurin M, Ulański P, Loo SCJ, Safrany A, Osso JA Jr, Duatti A, Katti KV. Jalilian AR, et al. Among authors: melendez alafort l. Pharmaceutics. 2022 May 15;14(5):1060. doi: 10.3390/pharmaceutics14051060. Pharmaceutics. 2022. PMID: 35631646 Free PMC article. Review.
57 results